z-logo
open-access-imgOpen Access
Lithium and Symptomatic Hyperparathyroidism
Author(s) -
Jambur Ananth,
Stephen E. Dubin
Publication year - 1983
Publication title -
journal of the royal society of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.38
H-Index - 81
eISSN - 1758-1095
pISSN - 0141-0768
DOI - 10.1177/014107688307601210
Subject(s) - discontinuation , hyperparathyroidism , lithium (medication) , exacerbation , parathyroid adenoma , medicine , psychopathology , lithium therapy , adenoma , psychosis , schizophrenia (object oriented programming) , depression (economics) , refractory (planetary science) , gastroenterology , pediatrics , psychiatry , endocrinology , bipolar disorder , biology , astrobiology , economics , macroeconomics
Hyperparathyroidism with or without adenoma has occasionally been reported in association with lithium treatment, and in symptomatic patients depression, psychosis and an exacerbation of existing psychopathology may occur. Three lithium-treated patients with hyperparathyroidism are reported, in whom discontinuation of lithium in one and removal of parathyroid adenomata in two led to both a reduction in plasma calcium levels and an improvement in their psychopathology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom